- Home
- GDYN vs CATX Comparison
GDYN vs CATX Comparison
Compare GDYN & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GDYN | CATX |
|---|---|---|
| Founded | 2006 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 509.3M | 414.0M |
| IPO Year | 2018 | 2018 |
Fundamental Metrics
Financial Performance| Metric | GDYN | CATX |
|---|---|---|
| Price | $5.76 | $2.94 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 9 |
| Target Price | $10.67 | ★ $12.11 |
| AVG Volume (30 Days) | ★ 2.3M | 2.1M |
| Earning Date | 04-30-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 120.00 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $111,283,000.00 | N/A |
| Revenue This Year | $10.16 | N/A |
| Revenue Next Year | $10.84 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.11 | $1.96 |
| 52 Week High | $10.61 | $6.16 |
Technical Indicators
Market Signals| Indicator | GDYN | CATX |
|---|---|---|
| Relative Strength Index (RSI) | 46.24 | 40.53 |
| Support Level | $5.46 | $2.86 |
| Resistance Level | $6.11 | $2.96 |
| Average True Range (ATR) | 0.29 | 0.20 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 42.95 | 12.50 |
Price Performance
Historical ComparisonAbout GDYN Grid Dynamics Holdings Inc.
Grid Dynamics Holdings Inc is a provider of technology consulting, platform and product engineering, and advanced analytics services. The company delivers tailored solutions in several industry verticals like Tech, Media and Telecom, Retail, Finance and Consumer Packaged goods (CPG)/manufacturing. The company derives maximum revenue from Retails. Geographically company earns revenue from North America, Europe and other regions.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.